相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Comparison of Antithrombotic Strategies in Chinese Patients in Sinus Rhythm after Bioprosthetic Mitral Valve Replacement: Early Outcomes from a Multicenter Registry in China
Heng Zhang et al.
CARDIOVASCULAR DRUGS AND THERAPY (2021)
Insights in ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia
Andreas Greinacher et al.
BLOOD (2021)
Thrombotic Thrombocytopenic Purpura: Pathophysiology, Diagnosis, and Management
Senthil Sukumar et al.
JOURNAL OF CLINICAL MEDICINE (2021)
A flow cytometric assay to detect platelet-activating antibodies in VITT after ChAdOx1 nCov-19 vaccination
Stefan Handtke et al.
BLOOD (2021)
Thrombotic microangiopathy in aHUS and beyond: clinical clues from complement genetics
Fadi Fakhouri et al.
NATURE REVIEWS NEPHROLOGY (2021)
The standard of care for immune thrombotic thrombocytopenic purpura today
X. Long Zheng
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)
First report of a de novo iTTP episode associated with an mRNA-based anti-COVID-19 vaccination
Severine de Bruijn et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)
COVID-19 and thrombotic microangiopathies
Nishant R. Tiwari et al.
THROMBOSIS RESEARCH (2021)
The Syndromes of Thrombotic Microangiopathy: A Critical Appraisal on Complement Dysregulation
Sjoerd A. M. E. G. Timmermans et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Soluble C-Type Lectin-Like Receptor 2 Is a Biomarker for Disseminated Intravascular Coagulation
Akitaka Yamamoto et al.
JOURNAL OF CLINICAL MEDICINE (2021)
D-dimer as a biomarker for assessment of COVID-19 prognosis: D-dimer levels on admission and its role in predicting disease outcome in hospitalized patients with COVID-19
Ayusha Poudel et al.
PLOS ONE (2021)
Platelet factor 4 inhibits ADAMTS13 activity and regulates the multimeric distribution of von Willebrand factor
Ishac Nazy et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Profiles of Coagulation and Fibrinolysis Activation-Associated Molecular Markers of Atypical Hemolytic Uremic Syndrome in the Acute Phase
Satoko Sakurai et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2020)
Pathogenesis of heparin-induced thrombocytopenia
Gowthami M. Arepally et al.
TRANSLATIONAL RESEARCH (2020)
Advances in the treatment of thrombotic thrombocytopenic purpura: repurposed drugs and novel agents
Andres Gomez-De Leon et al.
EXPERT REVIEW OF HEMATOLOGY (2020)
Serum D-dimer as a potential new biomarker for prognosis in patients with thrombotic thrombocytopenic purpura
Hai-Xu Wang et al.
MEDICINE (2020)
A regimen with caplacizumab, immunosuppression, and plasma exchange prevents unfavorable outcomes in immune-mediated TTP
Paul Coppo et al.
BLOOD (2020)
CD40 Ligand Levels in Pediatric Cohorts Correlate with Baseline Platelet Count and Transplant-Associated Mortality but Not with Endothelial Injury
Jeremy Rubinstein et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Elevated plasma levels of soluble C-type lectin-like receptor 2 (CLEC2) in patients with thrombotic microangiopathy
Yoshiki Yamashita et al.
THROMBOSIS RESEARCH (2019)
An update on pathogenesis and diagnosis of thrombotic thrombocytopenic purpura
Berangere S. Joly et al.
EXPERT REVIEW OF HEMATOLOGY (2019)
Caplacizumab as an emerging treatment option for acquired thrombotic thrombocytopenic purpura
Tugrul Elverdi et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2019)
Soluble CLEC-2 is generated independently of ADAM10 and is increased in plasma in acute coronary syndrome: comparison with soluble GPVI
Osamu Inoue et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2019)
Hereditary Thrombotic Thrombocytopenic Purpura
Johanna A. Kremer Hovinga et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Platelet function assays in diagnosis: an update
Paolo Gresele et al.
EXPERT REVIEW OF HEMATOLOGY (2019)
NLRP3 regulates platelet integrin αIIbβ3 outside-in signaling, hemostasis and arterial thrombosis
Jianlin Qiao et al.
HAEMATOLOGICA (2018)
NLRP3 regulates platelet integrin αIIbβ3 outside-in signaling, hemostasis and arterial thrombosis
Jianlin Qiao et al.
HAEMATOLOGICA (2018)
Mechanisms of receptor shedding in platelets
Samantha J. Montague et al.
BLOOD (2018)
Soluble CD40 Ligand and Oxidative Response Are Reciprocally Stimulated during Shiga Toxin-Associated Hemolytic Uremic Syndrome
Maria J. Abrey Recalde et al.
TOXINS (2017)
Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura
Flora Peyvandi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Thrombosis, Microangiopathies, and Inflammation
Karen Matevosyan et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2015)
A Novel Mechanism of Bacterial Toxin Transfer within Host Blood Cell-Derived Microvesicles
Anne-Lie Stahl et al.
PLOS PATHOGENS (2015)
CLEC-2 expression is maintained on activated platelets and on platelet microparticles
Eelo Gitz et al.
BLOOD (2014)
Circulating endothelial cells and progenitors as prognostic factors during autoimmune thrombotic thrombocytopenic purpura: results of a prospective multicenter French study
A. Widemann et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2014)
Syndromes of Thrombotic Microangiopathy
James N. George et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Elevated plasma levels of soluble platelet glycoprotein VI (GPVI) in patients with thrombotic microangiopathy
Yoshiki Yamashita et al.
THROMBOSIS RESEARCH (2014)
Complement activation by heme as a secondary hit for atypical hemolytic uremic syndrome
Marie Frimat et al.
BLOOD (2013)
Increased concentrations of soluble CD40 ligand platelet in patients with primary antiphospholipidic syndrome
Aida Galicia Lopez et al.
REUMATOLOGIA CLINICA (2013)
Biomarkers of platelet activation in acute coronary syndromes
Patrizia Ferroni et al.
THROMBOSIS AND HAEMOSTASIS (2012)
Complement activation on platelet-leukocyte complexes and microparticles in enterohemorrhagic Escherichia coli-induced hemolytic uremic syndrome
Anne-lie Stahl et al.
BLOOD (2011)
Endothelial dysfunction, platelet activation, thrombogenesis and fibrinolysis in patients with hypertensive crisis
Bert-Jan H. van den Born et al.
JOURNAL OF HYPERTENSION (2011)
Alternative Pathway Activation of Complement by Shiga Toxin Promotes Exuberant C3a Formation That Triggers Microvascular Thrombosis
Marina Morigi et al.
JOURNAL OF IMMUNOLOGY (2011)
Increased but highly dispersed levels of plasma glycocalicin in patients with disseminated intravascular coagulation
Shinji Kunishima et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
GPIb alpha-selective activation of platelets induces platelet signaling events comparable to GPVI activation events
Elizabeth E. Gardiner et al.
PLATELETS (2010)
Shear-induced interaction of platelets with von Willebrand factor results in glycoprotein Ibα shedding
Hong Cheng et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2009)
Renal and Cardiac Endothelial Heterogeneity Impact Acute Vascular Rejection in Pig-to-Baboon Xenotransplantation
C. Knosalla et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
CLEC-2 is an essential platelet-activating receptor in hemostasis and thrombosis
Frauke May et al.
BLOOD (2009)
Elevated Procalcitonin and C-Reactive Protein as Potential Biomarkers of Sepsis in a Subpopulation of Thrombotic Microangiopathy Patients
Yasuko O. Erickson et al.
JOURNAL OF CLINICAL APHERESIS (2009)
Measuring soluble platelet glycoprotein VI in human plasma by ELISA
Mohammad Al-Tamimi et al.
PLATELETS (2009)
Shiga Toxin and Lipopolysaccharide Induce Platelet-Leukocyte Aggregates and Tissue Factor Release, a Thrombotic Mechanism in Hemolytic Uremic Syndrome
Anne-lie Stahl et al.
PLOS ONE (2009)
Factor H dysfunction in patients with atypical hemolytic uremic syndrome contributes to complement deposition on platelets and their activation
Anne-Lie Stahl et al.
BLOOD (2008)
The thrombotic microangiopathies
Lawrence Copelovitch et al.
PEDIATRIC NEPHROLOGY (2008)
Lipopolysaccharide from enterohemorrhagic Escherichia coli binds to platelets through TLR4 and CD62 and is detected on circulating platelets in patients with hemolytic uremic syndrome
Anne-lie Stahl et al.
BLOOD (2006)
Platelet activation in hemolytic uremic syndrome
D Karpman et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2006)
Shiga toxin 2 and lipopolysaccharide induce human microvascular endothelial cells to release chemokines and factors that stimulate platelet function
F Guessous et al.
INFECTION AND IMMUNITY (2005)
Significance of elevation in cell-derived microparticles after allogeneic stem cell transplantation: transient elevation of platelet-derived microparticles in TMA/TTP
S Nomura et al.
BONE MARROW TRANSPLANTATION (2005)
Complement activation: the missing link between ADAMTS-13 deficiency and microvascular thrombosis of thrombotic microangiopathies
MP Ruiz-Torres et al.
THROMBOSIS AND HAEMOSTASIS (2005)
Enhanced P-selectin expression and increased soluble CD40 Ligand in patients with Type 1 diabetes mellitus and microangiopathy:: evidence for platelet hyperactivity and chronic inflammation
M Yngen et al.
DIABETOLOGIA (2004)
Differences of soluble CD40L in sera and plasma: Implications on CD40L assay as a marker of thrombotic risk
ER Ahn et al.
THROMBOSIS RESEARCH (2004)
Mechanisms of disease - Thrombotic microangiopathies
JL Moake
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Verotoxin-1-induced up-regulation of adhesive molecules renders microvascular endothelial cells thrombogenic at high shear stress
M Morigi et al.
BLOOD (2001)
分享论文
